NavDx Optimizing HPV+ Cancer Surveillance for Patients

NavDx is the first and only clinically validated circulating tumor tissue modified viral (TTMV)-HPV DNA blood test that aids in the detection of HPV-driven cancer. Using NavDx to track your TTMV
Score and detect if cancer is still in your body can guide the way to personalizing your cancer care.